MKA031
MKA031 (compound 6y) is a non-competitive MIF inhibitor with an IC50 value of 1.7 μM. MKA031 (compound 6y) interferes with MIF/AIF interaction, MIF nuclear translocation, and N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) -induced dependent cell death. MKA031 can be used in the study of chronic hepatitis C virus infection[1].
Product Specifications
CAS Number
[2951012-00-1]
UNSPSC
12352005
Target
Macrophage migration inhibitory factor (MIF)
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/mka031.html
Purity
98.69
Solubility
DMSO : 25 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NC1=CC=CC=C1)C2=CC=C(C=C2)N3N=NC(C(NCC4=CC=CS4)=O)=C3
Molecular Formula
C21H17N5O2S
Molecular Weight
403.46
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Recombinant Horse Regulated On Activation In Normal T-Cell Expressed And Secreted (RANTES)
Recombinant Horse Regulated On Activation In Normal T-Cell Expressed And Secreted (RANTES)
Recombinant Horse Regulated On Activation In Normal T-Cell Expressed And Secreted (RANTES)
PASD1, ID (PASD1, PAS domain-containing protein 1, Cancer/testis antigen 63, OX-TES-1) (MaxLight 750)